Recent News

• 10.03.2025 - Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 10.03.2025 - Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 10.02.2025 - Taysha Gene Therapies Announces FDA Breakthrough Therapy Designation and Provides Positive Regulatory Update on TSHA-102 in Rett Syndrome
• 10.02.2025 - Taysha Gene Therapies Announces FDA Breakthrough Therapy Designation and Provides Positive Regulatory Update on TSHA-102 in Rett Syndrome
• 09.05.2025 - Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 09.05.2025 - Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 10.02.2025 - 8-K Current report
• 10.02.2025 - EX-99.1 EX-99.1
• 09.22.2025 - 144 Report of proposed sale of securities
• 09.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.10.2025 - 144 Report of proposed sale of securities
• 08.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.21.2025 - 144 Report of proposed sale of securities
• 08.21.2025 - 144 Report of proposed sale of securities
• 08.21.2025 - 144 Report of proposed sale of securities